• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童嗜酸性食管炎患者报告症状指标的验证:定性方法。

Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods.

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

出版信息

BMC Gastroenterol. 2011 Nov 18;11:126. doi: 10.1186/1471-230X-11-126.

DOI:10.1186/1471-230X-11-126
PMID:22099448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3228698/
Abstract

BACKGROUND

Previous attempts to measure symptoms in pediatric Eosinophilic Esophagitis (EoE) have not fully included patients and parents in the item development process. We sought to identify and validate key patient self-reported and parent proxy-reported outcomes (PROs) specific to EoE.

METHODS

We developed methodology for focus and cognitive interviews based on the Food and Drug Administration (FDA) guidelines for PROs, the validated generic PedsQL™ guidelines, and the consolidated criteria for reporting qualitative research (COREQ). Both child (ages 8-12 and 13-18) and parent-proxy (ages 2-4, 5-7, 8-12, and 13-18) interviews were conducted.

RESULTS

We conducted 75 interviews to construct the new instrument. Items were identified and developed from individual focus interviews, followed by cognitive interviews for face and content validation. Initial domains of symptom frequency and severity were developed, and open-ended questions were used to generate specific items during the focus interviews. Once developed, the instrument construct, instructions, timeframe, scoring, and specific items were systematically reviewed with a separate group of patients and their parents during the cognitive interviews.

CONCLUSIONS

To capture the full impact of pediatric EoE, both histologic findings and PROs need to be included as equally important outcome measures. We have developed the face and content validated Pediatric Eosinophilic Esophagitis Symptom Score (PEESS™ v2.0). The PEESS™ v2.0 metric is now undergoing multisite national field testing as the next iterative instrument development phase.

摘要

背景

之前尝试测量小儿嗜酸性食管炎(EoE)症状的研究并未充分让患者和家长参与条目开发过程。我们旨在确定并验证特定于 EoE 的关键患者自评和家长代理报告结局(PRO)。

方法

我们根据食品和药物管理局(FDA)PRO 指南、经过验证的通用 PedsQL™ 指南和定性研究报告的统一标准(COREQ)制定了焦点和认知访谈方法。我们对儿童(8-12 岁和 13-18 岁)和家长代理(2-4 岁、5-7 岁、8-12 岁和 13-18 岁)进行了访谈。

结果

我们进行了 75 次访谈以构建新工具。从个体焦点访谈中确定和开发了条目,随后进行了认知访谈以进行表面和内容验证。最初开发了症状频率和严重程度的领域,并在焦点访谈中使用开放式问题生成具体条目。一旦开发完成,在认知访谈中,我们与另一组患者及其家长一起系统地审查了工具结构、说明、时间范围、评分和具体条目。

结论

为了全面评估小儿 EoE,组织学发现和 PRO 都需要作为同等重要的结局指标。我们已经开发了经过表面和内容验证的小儿嗜酸性食管炎症状评分(PEESS™ v2.0)。PEESS™ v2.0 指标目前正在进行多中心全国现场测试,作为下一迭代的仪器开发阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50f2/3228698/5c412bbe338c/1471-230X-11-126-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50f2/3228698/76d1db8195fc/1471-230X-11-126-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50f2/3228698/5c412bbe338c/1471-230X-11-126-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50f2/3228698/76d1db8195fc/1471-230X-11-126-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50f2/3228698/5c412bbe338c/1471-230X-11-126-2.jpg

相似文献

1
Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods.儿童嗜酸性食管炎患者报告症状指标的验证:定性方法。
BMC Gastroenterol. 2011 Nov 18;11:126. doi: 10.1186/1471-230X-11-126.
2
Development of the Pediatric Quality of Life Inventory™ Eosinophilic Esophagitis module items: qualitative methods.《儿科生活质量量表™ 嗜酸性食管炎模块项目的开发:定性方法》
BMC Gastroenterol. 2012 Sep 25;12:135. doi: 10.1186/1471-230X-12-135.
3
Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites.在多个 CEGIR 研究中心,父母报告和儿童报告的结局与嗜酸性食管炎的组织学表现一致。
J Allergy Clin Immunol. 2018 Jul;142(1):130-138.e1. doi: 10.1016/j.jaci.2018.05.014. Epub 2018 May 29.
4
Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.小儿嗜酸性粒细胞性食管炎症状评分(PEESS v2.0)可识别该疾病关键临床特征的组织学和分子学关联。
J Allergy Clin Immunol. 2015 Jun;135(6):1519-28.e8. doi: 10.1016/j.jaci.2015.03.004.
5
Patient reported data integration for management of Eosinophilic Esophagitis.患者报告数据整合用于嗜酸性粒细胞性食管炎的管理。
Dis Esophagus. 2022 Oct 14;35(10). doi: 10.1093/dote/doac012.
6
Quality of life in paediatric eosinophilic oesophagitis: what is important to patients?儿童嗜酸性粒细胞性食管炎的生活质量:对患者而言什么是重要的?
Child Care Health Dev. 2012 Jul;38(4):477-83. doi: 10.1111/j.1365-2214.2011.01265.x. Epub 2011 Jun 15.
7
Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS.土耳其版儿童嗜酸性食管炎症状评分量表(Tr-PEESS v2.0)的信度和效度研究促成了一种新的儿童嗜酸性食管炎量表的发展:GaziESAS。
Turk J Gastroenterol. 2021 Apr;32(4):365-373. doi: 10.5152/tjg.2020.20674.
8
Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires*.患者及照料者对儿童嗜酸性粒细胞性食管炎及新开发症状问卷的看法*
Curr Med Res Opin. 2008 Dec;24(12):3369-81. doi: 10.1185/03007990802536900.
9
A novel pediatric Eosinophilic Esophagitis Symptoms and Adaptive Behavior Scale for different ages: GaziESAS v2.0.一种适用于不同年龄段的新型儿科嗜酸性食管炎症状和适应行为量表:GaziESAS v2.0。
Pediatr Allergy Immunol. 2023 Jun;34(6):e13974. doi: 10.1111/pai.13974.
10
Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.嗜酸性食管炎成人患者基于症状的活动指数的开发与验证
Gastroenterology. 2014 Dec;147(6):1255-66.e21. doi: 10.1053/j.gastro.2014.08.028. Epub 2014 Aug 23.

引用本文的文献

1
Experiences of symptom burden among young children born with esophageal atresia-tracheoesophageal fistula: a US focus group study.食管闭锁-气管食管瘘患儿的症状负担体验:一项美国焦点小组研究
Orphanet J Rare Dis. 2025 Aug 18;20(1):438. doi: 10.1186/s13023-025-03939-2.
2
A New Instrument to Define Parental Fear Regarding Feeding Their Children: A Reliability and Validity Study.一种用于界定父母对喂养孩子的恐惧的新工具:一项信效度研究。
Dysphagia. 2025 Jan 18. doi: 10.1007/s00455-024-10800-4.
3
Clinical monitoring of eosinophilic esophagitis using the esophageal string test.

本文引用的文献

1
Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.接受羟基脲治疗的镰状细胞病患儿健康相关生活质量的差异。
J Pediatr Hematol Oncol. 2011 May;33(4):251-4. doi: 10.1097/MPH.0b013e3182114c54.
2
Two-year trends in psychosocial functioning after adolescent Roux-en-Y gastric bypass.青少年 Roux-en-Y 胃旁路术后两年的心理社会功能变化趋势。
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):727-32. doi: 10.1016/j.soard.2011.01.034. Epub 2011 Mar 5.
3
Reslizumab for pediatric eosinophilic esophagitis.
使用食管线试验对嗜酸性食管炎进行临床监测。
J Allergy Clin Immunol Pract. 2025 Mar;13(3):705-707.e1. doi: 10.1016/j.jaip.2024.12.030. Epub 2024 Dec 28.
4
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis.局部用类固醇每日一次或每日两次治疗在嗜酸性粒细胞性食管炎中产生相似反应。
Clin Gastroenterol Hepatol. 2025 May;23(6):946-953.e1. doi: 10.1016/j.cgh.2024.10.016. Epub 2024 Nov 17.
5
Odynophagia and Retrosternal Pain Are Common in Eosinophilic Esophagitis and Associated with an Increased Overall Symptom Severity.吞咽困难和胸骨后疼痛在嗜酸性食管炎中常见,并与整体症状严重程度增加相关。
Dig Dis Sci. 2024 Oct;69(10):3853-3862. doi: 10.1007/s10620-024-08586-4. Epub 2024 Aug 8.
6
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis.氯沙坦治疗可减轻嗜酸性食管炎中部分患者的食管嗜酸性粒细胞炎症。
J Allergy Clin Immunol Pract. 2024 Sep;12(9):2427-2438.e3. doi: 10.1016/j.jaip.2024.07.011. Epub 2024 Jul 25.
7
Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis.儿童和父母报告的嗜酸性食管炎患者结局的长期耐久性。
J Allergy Clin Immunol. 2024 Nov;154(5):1232-1240.e12. doi: 10.1016/j.jaci.2024.07.011. Epub 2024 Jul 25.
8
Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis.嗜酸性食管炎严重程度及缓解标准的评估
Biomedicines. 2023 Dec 1;11(12):3204. doi: 10.3390/biomedicines11123204.
9
Treatment of Pediatric Eosinophilic Esophagitis: Traditional and Novel Therapies.儿科嗜酸性食管炎的治疗:传统与新型疗法。
Curr Gastroenterol Rep. 2023 Nov;25(11):289-298. doi: 10.1007/s11894-023-00893-6. Epub 2023 Sep 2.
10
Medical treatment of eosinophilic esophagitis.嗜酸粒细胞性食管炎的治疗。
Cochrane Database Syst Rev. 2023 Jul 20;7(7):CD004065. doi: 10.1002/14651858.CD004065.pub4.
瑞利珠单抗治疗小儿嗜酸性食管炎。
Immunotherapy. 2010 Jul;2(4):461-5. doi: 10.2217/imt.10.41.
4
Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study.三种环索奈德剂量与安慰剂在哮喘儿童中的疗效和安全性:RAINBOW 研究。
Respir Med. 2010 Nov;104(11):1618-28. doi: 10.1016/j.rmed.2010.06.012. Epub 2010 Jul 8.
5
Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.口服黏性布地奈德在一项随机、安慰剂对照试验中对嗜酸细胞性食管炎患儿有效。
Gastroenterology. 2010 Aug;139(2):418-29. doi: 10.1053/j.gastro.2010.05.001. Epub 2010 May 7.
6
A pilot study to assess the efficacy of biofeedback-assisted relaxation training as an adjunct treatment for pediatric functional dyspepsia associated with duodenal eosinophilia.一项评估生物反馈辅助放松训练作为十二指肠嗜酸性粒细胞增多相关小儿功能性消化不良辅助治疗的疗效的初步研究。
J Pediatr Psychol. 2010 Sep;35(8):837-47. doi: 10.1093/jpepsy/jsq010. Epub 2010 Feb 25.
7
From the item to the outcome: the promising prospects of PROMIS.从项目到结果:PROMIS 的广阔前景。
Arthritis Res Ther. 2010;12(1):104. doi: 10.1186/ar2910. Epub 2010 Feb 1.
8
A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation.一种用于识别嗜酸性粒细胞性食管炎儿科患者并将症状与炎症相关联的症状评分工具。
Ann Allergy Asthma Immunol. 2009 Nov;103(5):401-6. doi: 10.1016/S1081-1206(10)60359-6.
9
The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease.《梅奥吞咽问卷-30 版》:一种用于食管疾病成人介入试验的工具的可靠性和有效性的文献记录。
Dysphagia. 2010 Sep;25(3):221-30. doi: 10.1007/s00455-009-9246-8. Epub 2009 Oct 24.
10
Improvement of quality of life in children with slow transit constipation after treatment with transcutaneous electrical stimulation.经皮电刺激治疗后慢传输型便秘患儿生活质量的改善
J Pediatr Surg. 2009 Jun;44(6):1268-72; discussion 1272. doi: 10.1016/j.jpedsurg.2009.02.031.